“NIH leadership is not yet ready to significantly accelerate NIH’s approach and commitment to ME because they feel the science is not ready, and that the field lacks the needed researchers and high-quality grant applications.”
I can imagine that his may well be the situation and I think the NIH may be right. I am not hearing of lots of projects not being funded by NIH that look worthy of big funding.
NIH is giving out funding. The money is available. Parity with other conditions means the same height of bar for research quality. There are serious issues about quality evaluation but it makes no sense to dish out money unless there is a reasonable chance of success.
I can imagine that it does not help persuade the NIH to have some of the comments that follow. They illustrate why there has to be quality control. Looking for moulds is not going to help anyone and nor, I think, is a focus on ICC. The Incline Outbreak is history and probably of no real interest now.
What I think is needed is some objective clinical documentation of the illness in day to day circumstances that leads to intelligent research questions about its origin. I think a lot of research groups are starting at the wrong end.
What I was wondering @Jonathan Edwards, is what you mean by "objective clinical documentation of the illness in day to day circumstances". I have my picture of it: document signs, symptoms, testing, on a daily/as lived basis - what happens to pwME in their real world, and wrap this up in published studies. If daily activity patterns encompass this, then I understand what you mean.
My understanding of your point about "research groups are starting at the wrong end" is that they need to do basics first: objective clinical documentation of the day to day circumstances.
You are probably aware the CCC, page 18 and 19 includes Neurally mediated hypotension (NMH), Postural orthostatic tachycardia syndrome (POTS), and Delayed postural hypotension under the OI heading, as "commonly seen in ME/CFS patients":
http://www.mefmaction.com/images/stories/Medical/ME-CFS-Consensus-Document.pdf
I don't have any explanation for these various shades of OI in our population. I have had a couple tests, one in a preliminary study, and one with a specialist that documented an abnormally high HR increase with standing (POTS). Early on I had a doctor's office test that documented NMH.
I get the impression your view is that researchers are rushing ahead, but do not have adequate documentation of physiological problems. This is concerning and confusing, as many of us turn to the CCC, and other case definitions for an overall review of research information about physiological abnormalities.
I thought the basics were already done.